Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
--------
1:37
--------
1:37
Outcomes Following Acute Plasma Exchange for MOGAD - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
--------
3:08
--------
3:08
Safety and Efficacy of Satralizumab in Patients with Generalized MG
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
--------
4:06
--------
4:06
UNITE Randomized Clinical Trial
Dr. Bradley Ong discusses the efficacy and safety of fremanezumab in adults with migraine and comorbid major depressive disorder. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2833452
--------
2:37
--------
2:37
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss ways to empower professionals in the fields of neurology and research.
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Brasil